Drugs / Mephentermine

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) WYAMINE SULFATE 1951-12-29 fda.gov

Trials 1 · a red edge is where a trial was stopped

today
US approved 1951
NCT05706727 · Ph 3
1950195119521953195419551956195719581959196019611962196319641965196619671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05706727 Mar 2023 → Apr 2024 KIST Medical and Teaching Hospital Completed No outcome recorded

Evidence & citations 13 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Mephentermine ClinicalTrials.gov intervention name — accepted as the source's own label NCT05706727
Known as Mefentermina ChEMBL registry synonym — accepted as the source's own label CHEMBL1201234
Known as MEPHENTERMINE SULFATE ChEMBL registry synonym — accepted as the source's own label CHEMBL1201234
Known as Mephentermine sulfate dihydrate ChEMBL registry synonym — accepted as the source's own label CHEMBL1201234
Known as Mephentermine sulphate ChEMBL registry synonym — accepted as the source's own label CHEMBL1201234
Known as Mephine ChEMBL registry synonym — accepted as the source's own label CHEMBL1201234
Known as NSC-758424 ChEMBL registry synonym — accepted as the source's own label CHEMBL1201234
Known as Wyamine ChEMBL registry synonym — accepted as the source's own label CHEMBL1201234
Known as Wyamine sulfate ChEMBL registry synonym — accepted as the source's own label CHEMBL1201234
Known as Wyamine sulphate ChEMBL registry synonym — accepted as the source's own label CHEMBL1201234
Action Activate “Mephentermine non catecholamine nondirectly acts on both adrenergic alpha and beta receptors and indirectly by releasing norepinephrine and epinephrine that increases blood...” NCT05706727
Modality Small molecule CHEMBL1201234
Route Intravenous intravenous bolus dose of mephenteramine 6mg” NCT05706727